Fundacio Clinic Barcelona
14
4
5
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
14.3%
2 terminated/withdrawn out of 14 trials
77.8%
-8.7% vs industry average
21%
3 trials in Phase 3/4
29%
2 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Assessment of TetraSOD® Efficacy to Improve Semen Parameters in Men With Idiopathic Infertility
Role: collaborator
Digital Pathology and AI for Liver Outcomes in MASLD
Role: collaborator
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
Role: lead
Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy
Role: lead
Study to Verify the Efficacy of a Product Containing 125 mg of TetraSOD® for the Treatment of Male Infertility
Role: collaborator
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project
Role: collaborator
Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
Role: collaborator
Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS
Role: lead
Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation
Role: collaborator
Tissue Doppler Imaging (TDI) Versus Electrocardiography (ECG) Interventricular Pacing Delay Optimization in Cardiac Resynchronization Therapy (CRT)
Role: collaborator
Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation
Role: collaborator
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children
Role: collaborator
Plasma Exchange for Renal Vasculitis
Role: collaborator
Sodium Tungstate in Obesity
Role: collaborator
All 14 trials loaded